OrbiMed Capital GP VI LLC (CIK 1682115) reported 42 SEC Form 4 insider transactions across 8 companies over the past 18 months (most recent 2026-04-23). Recent activity: Buy PRLD (1.7M shares), Buy PRLD (1.1M shares), Sell ACET (29,319 shares), Sell ACET (2,400 shares), Sell ACET (32,523 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-23 | Prelude Therapeutics Inc (PRLD) | Director | Buy | 1.7M | $7.5M |
| 2026-04-23 | Prelude Therapeutics Inc (PRLD) | Director | Buy | 1.1M | $5.0M |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 29,319 | $191,453 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 2,400 | $15,312 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 32,523 | $204,570 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 40,416 | $263,512 |
| 2025-10-10 | Adicet Bio, Inc. (ACET) | Insider | Buy | 1.5M | $0 |
| 2025-10-10 | Adicet Bio, Inc. (ACET) | Insider | Buy | 3.5M | $0 |
| 2025-08-12 | Turnstone Biologics Corp. (TSBX) | Director | Sell | 3.1M | $0 |
| 2025-07-30 | ImageneBio, Inc. (IKNA) | Director | Buy | 83,611 | $208,191 |
| 2025-05-16 | NeuroPace Inc (NPCE) | Insider | Sell | 134,136 | $2.1M |
| 2025-05-16 | NeuroPace Inc (NPCE) | Insider | Sell | 34,000 | $541,960 |
| 2025-04-11 | Compass Therapeutics, Inc. (CMPX) | Director | Sell | 3.6M | $5.7M |
| 2025-04-04 | Edgewise Therapeutics, Inc. (EWTX) | Director | Buy | 372,578 | $7.5M |
| 2025-04-04 | Edgewise Therapeutics, Inc. (EWTX) | Director | Buy | 124,193 | $2.5M |
| 2025-03-26 | Disc Medicine, Inc. (IRON) | Director | Sell | 1,956 | $105,839 |
| 2025-03-26 | Disc Medicine, Inc. (IRON) | Director | Sell | 3,026 | $163,737 |
| 2025-03-26 | Disc Medicine, Inc. (IRON) | Director | Sell | 756 | $40,907 |
| 2025-03-21 | Disc Medicine, Inc. (IRON) | Director | Sell | 13,517 | $730,188 |
| 2025-03-21 | Disc Medicine, Inc. (IRON) | Director | Sell | 20,911 | $1.1M |
| 2025-03-21 | Disc Medicine, Inc. (IRON) | Director | Sell | 5,228 | $282,417 |
| 2025-03-21 | Disc Medicine, Inc. (IRON) | Director | Sell | 941 | $50,823 |
| 2025-03-21 | Disc Medicine, Inc. (IRON) | Director | Sell | 1,457 | $78,693 |
| 2025-03-21 | Disc Medicine, Inc. (IRON) | Director | Sell | 364 | $19,660 |
| 2025-03-21 | Disc Medicine, Inc. (IRON) | Director | Sell | 3,412 | $184,248 |
Source: SEC Form 4 filings · as of 2026-04-23